Market Access Matters
Brought to you by the team at Access Infinity, this podcast shines a spotlight on the people in market access. In each episode we interview a different industry professional to discover their journey into market access, what inspires them and what they feel is on the horizon for this this ever-changing and exciting industry.
Podcasting since 2023 • 31 episodes
Market Access Matters
Latest Episodes
Navigating Global Policy Shifts with Nikhil Taxak
In this episode we sit down with Nikhil Taxak, Head of Pricing and Market Access Data Analytics at Access Infinity, to explore the rapidly evolving market access landscape.From the US Most Favored Nation (MFN) policy and Germany's Medic...
•
Season 4
•
Episode 8
•
26:37
Beyond the Headlines: Understanding MFN's True Impact on Market Access
In this episode, we're joined by Louisa Oliver Byrne, Senior Consultant at Access Infinity. We learn about the complexities of the Most Favored Nation (MFN) policy and its implications for pharmaceutical market access. Louisa shares insights fr...
•
Season 4
•
Episode 7
•
19:22
Revolutionary Strategies in Orphan Drug Development with Isabel Rubio
In this episode, we invite Access Infinity Partner, Isabel Rubio back to the podcast to explore the unique challenges and innovative solutions reshaping market access and pricing within rare disease. Isabel shares insights fr...
•
Season 4
•
Episode 6
•
18:29
Elevating launch excellence: The strategic value of early market access involvement with Lizzie Shanahan, Sanofi
In this insightful episode we speak with Lizzie Shanahan, Global Access AI Strategy Lead at Sanofi. With over six years' experience at Sanofi and a rich background in commercial roles, Lizzie shares her unique journey into the world of market a...
•
Season 4
•
Episode 5
•
30:22
Getting ready for the JCA: Why cross-functional collaboration matters with Silvy Mardiguian, BeiGene
In this episode, we speak with Silvy Mardiguian, Senior Director and Head of HEOR for Europe & New Markets at BeiGene. Silvy has been co-leading BeiGene’s preparedness and organisational readiness for the new Joint Clinical Ass...
•
Season 4
•
Episode 4
•
18:35